Malvern Panalytical Pharmaceuticals was founded in 1971 and is headquartered in Malvern, Worcestershire, GB. The company operates across the household appliances and pharma sectors.
Its technical expertise spans immunology, immuno‑oncology, oncology, neuroscience, custom assay development and discovery, preclinical, clinical and regulatory bioanalysis, DMPK and ADMET services, biophysical assays, histology, toxicology, endocrine disruptor assays, deformulation and IVBE services, synthetic chemistry, computational chemistry, medicinal chemistry, process R&D, GMP manufacture, immune and cell‑based assays, analytical method development & transfer, analytical instrument manufacture, laser diffraction, dynamic light scattering, microcalorimetry, X‑ray diffraction and X‑ray fluorescence.
With 1,000–5,000 employees, the company generates between $500 million and $1 billion in revenue. Key leaders include Marie Piazza (Consultant – Business Development Executive), Dean Bornilla (Chief Commercial Officer), Alex Hasler (Director of Business Development, East Coast US) and Li Luo (Consultant | Business Development Director).